<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "DOCEtaxel inj VIAL>
<dose><value>75</value>
<value>100</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>DOCEtaxel inj VIAL</value>
</drugname><strength><value>20 mg</value>
<value>80 mg</value>
</strength><frequency><value>ONCE</value>
</frequency><instruction><value>DAY 1 of 21. Administer dose in the following volume and at the corrsponding rate: a) Dilute dose in 100 mL - 0.9% sodium chloride (for doses less than 90 mg) and administer over 30 minutes to 1 hour. Titration usually not required. b) Dilute dose in 250 mL - 0.9% sodium chloride (for doses 90 to 200 mg) and administer at 100 mL/hour for first 15 minutes, then complete infusion over 45 minutes. c) Dilute dose in 500 mL - 0.9% sodium chloride (for doses greater than 200 mg) and administer at 100 mL/hour for first 15 minutes, then complete infusion over 1 hour.</value>
<value>DAY 1 of 21. Administer dose in the following volume and at the corrsponding rate: a) Dilute dose in 100 mL - 0.9% sodium chloride (for doses less than 90 mg) and administer over 30 minutes to 1 hour. Titration usually not required. b) Dilute dose in 250 mL - 0.9% sodium chloride (for doses 90 to 200 mg) and administer at 100 mL/hour for first 15 minutes, then complete remaining infusion over 45 minutes. c) Dilute dose in 500 mL - 0.9% sodium chloride (for doses greater than 200 mg) and administer at 100 mL/hour for first 15 minutes, then complete remaining infusion over 1 hour.</value>
<value>DAY 1 of 21. Administer dose in the following volume and at the corrsponding rate: a) Dilute dose in 100 mL - 0.9% sodium chloride (for doses less than 90 mg) and administer over 30 minutes to 1 hour. Titration usually not required. b) Dilute dose in 250 mL - 0.9% sodium chloride (for doses 90 to 200 mg) and administer at 100 mL/hour for first 15 minutes, then complete remaining infusion over 45 minutes. c) Dilute dose in 500 mL - 0.9% sodium chloride (for doses greater than 200 mg) and administer at 100 mL/hour for first 15 minutes, then complete remaining infusion over 1 hour. [Cycle 1 only]</value>
<value>DAY 1 of 21. Administer dose in the following volume and at the corrsponding rate: a) Dilute dose in 100 mL - 0.9% sodium chloride (for doses less than 90 mg) and administer over 30 minutes to 1 hour. Titration usually not required. b) Dilute dose in 250 mL - 0.9% sodium chloride (for doses 90 to 200 mg) and administer at 100 mL/hour for first 15 minutes, then complete remaining infusion over 45 minutes. c) Dilute dose in 500 mL - 0.9% sodium chloride (for doses greater than 200 mg) and administer at 100 mL/hour for first 15 minutes, then complete remaining infusion over 1 hour. [Cycles 2, 3 &amp; 4]</value>
<value>DAY 1 of 21. Administer dose in the following volume and at the corrsponding rate: a) Dilute dose in 100 mL - 0.9% sodium chloride (for doses less than 90 mg) and administer over 30 minutes to 1 hour. Titration usually not required. b) Dilute dose in 250 mL - 0.9% sodium chloride (for doses 90 to 200 mg) and administer at 100 mL/hour for first 15 minutes, then complete remaining infusion over 45 minutes. c) Dilute dose in 500 mL - 0.9% sodium chloride (for doses greater than 200 mg) and administer at 100 mL/hour for first 15 minutes, then complete remaining infusion over 1 hour. </value>
<value>DAY 1 of 21. Administer dose in the following volume and at the corrsponding rate: a) Dilute dose in 100 mL - 0.9% sodium chloride (for doses less than 90 mg) and administer over 30 minutes to 1 hour. Titration usually not required. b) Dilute dose in 250 mL - 0.9% sodium chloride (for doses 90 to 200 mg) and administer at 100 mL/hour for first 15 minutes, then complete remaining infusion over 45 minutes. c) Dilute dose in 500 mL - 0.9% sodium chloride (for doses greater than 200 mg) and administer at 100 mL/hour for first 15 minutes, then complete remaining infusion over 1 hour. [Cycle 1]</value>
<value>DAY 1 of 21. Administer dose in the following volume and at the corrsponding rate: a) Dilute dose in 100 mL - 0.9% sodium chloride (for doses less than 90 mg) and administer over 30 minutes to 1 hour. Titration usually not required. b) Dilute dose in 250 mL - 0.9% sodium chloride (for doses 90 to 200 mg) and administer at 100 mL/hour for first 15 minutes, then complete remaining infusion over 45 minutes. c) Dilute dose in 500 mL - 0.9% sodium chloride (for doses greater than 200 mg) and administer at 100 mL/hour for first 15 minutes, then complete remaining infusion over 1 hour. [Cycles 2 - 4]</value>
</instruction><volume><value>0.5 mL</value>
<value>2 mL</value>
</volume><units><value>mg/m2</value>
</units><additionalnotes><value>If ANC is greater than or equal to 1.5 AND Plts are greater than or equal to 100 x 109/L. Give as ordered. If ANC is less than 1.5 OR Plts are less than 100 x 109/L: Delay chemotherapy 1 week.</value>
<value>If ANC is greater than or equal to 1.5 AND Plts are greater than or equal to 100 x 109/L: Give as ordered. If ANC is less than 1.5 OR Plts are less than 100 x 109/L: Delay 1 week.</value>
<value>If ANC is greater than or equal to 1.5 AND Plts are greater than or equal to 100 x 109/L: Give as ordered. If ANC is less than 1.5 OR Plts are less than 100 x 109/L: Delay 1 week. If LVEF is WNL and less than 10% decrease from baseline: Continue treatment. If LVEF is WNL and 10 to 15% decrease from baseline: Continue treatment. If LVEF is WLN and greater than 15% decrease from baseline: Hold treatment. If LVEF is 1 to 5% below LLN and less than 10% decrease from baseline: Continue treatment. If LVEF is 1 to 5% below LLN and 10 to 15% decrease baseline: Hold treatment. If LVEF is 1 to 5% below LLN and greater than 15% decrease from baseline: Hold treatment. If LVEF is greater than 5% below LLN and less than 10% decrease from baseline: Continue treatment. If LVEF is greater than 5% below LLN and 10 to 15% decrease from baseline: Hold treatment. If LVEF is greater than 5% below LLN and greater than 15% decrease from baseline: Hold treatment. Resume if criteria for continuation met. Discontinue if 2 consecutive &amp;quot;holds&amp;quot; or a total of 3 &amp;quot;holds&amp;quot; occur.</value>
<value>If ANC is greater than or equal to 1.5 AND Plts are greater than or equal to 100 x 109/L: Give as ordered. If ANC is less than 1.5 OR Plts are less than 100 x 109/L: Delay 1 week. [Part 2: Cycle 1]</value>
</additionalnotes><population><value>DOCEtaxel. Non-Small Cell Lung Cancer</value>
<value>Fluorouracil, Epirubicin, Cyclophosphamide (FEC) followed by DOCEtaxel. Breast Cancer (NEOADJUVANT Treatment).</value>
<value>Fluorouracil, Epirubicin, Cyclophosphamide (FEC) followed by DOCEtaxel &amp; Trastuzumab</value>
<value>Fluorouracil, Epirubicin, Cyclophosphamide (FEC) followed by DOCEtaxel and Trastuzumab. Breast Cancer (NEOADJUVANT Treatment).</value>
<value>DOXOrubicin, Cyclophosphamide (AC) followed by DOCEtaxel. Breast Cancer (NEOADJUVANT Treatment).</value>
<value>DOXOrubicin, Cyclophosphamide (AC) followed by DOCEtaxel and Trastuzumab. Breast Cancer (NEOADJUVANT Treatment).</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3312</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3313</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose><value>YES</value>
</maximumprndose></drug>